Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001390202-26-000007
Filing Date
2026-04-29
Accepted
2026-04-29 11:16:04
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9732
  Complete submission text file 0001390202-26-000007.txt   11534
Mailing Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017
Business Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017 212-938-6325
Laurion Capital Management LP (Filed by) CIK: 0001390202 (see all company filings)

EIN.: 562504425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Subject) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92742 | Film No.: 26911863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)